Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-11-02-2002
Volume26
Issue 11

Residual Solvent Analysis in Pharmaceuticals

Author(s):

Anil M. Dwivedi, PhD

The author discusses the current pharmacopeial status of the acceptance limits and classifications of pharmaceutical residual solvents.

External Link - article-38267.pdf

Articles in this issue
Contract Services
Major Changes Ahead for FDA
Estimation of Distribution Coefficients from the Partition Coefficient and pKa
Residual Solvent Analysis in Pharmaceuticals
Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
PharmTech Weekly News Roundup
Related Content
Silver Spring, MD, USA - June 25, 2022: Closeup of the FDA sign seen at its headquarters campus in Silver Spring, Maryland. FDA is a federal agency of the Department of Health and Human Services | Image Credit: © Tada Images - stock.adobe.com.
September 4th 2025

Pharma Implications of Paul Offit’s Removal from Vaccine Advisory Committee

Christopher Cole
Drug Solutions Podcast: Sustainable Solutions for Biopharma
September 4th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
Chemistry professor wearing a lab coat and gloves, demonstrating a vibrant chemical solution in a beaker to engaged students during an interactive experiment in a university laboratory | Image Credit: ©DusanJelicic - stock.adobe.com
September 4th 2025

Focusing on the Fundamentals of Formulation

Evonne Brennan
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
September 4th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
David Cali is senior director of Security & DEA Compliance at Reworld.
September 4th 2025

Manufacturer Guidelines for the Secure Destruction of Controlled Substance Pharmaceuticals

David Cali
South San Francisco, CA, USA - Mar 1, 2020: American clinical-stage biopharmaceutical company Cytokinetics, Inc.'s Headquarters in South San Francisco, California. | Image Credit: © Tada Images - stock.adobe.com
September 4th 2025

Aficamten Bests Metoprolol in Cytokinetics' Trial for Obstructive Hypertrophic Cardiomyopathy

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.